Investec Bank Plc has submitted a Form 8.5 regulatory filing disclosing dealings in Advanced Medical Solutions Group Plc ordinary shares on September 8, 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status acting in a client-serving capacity.
Investec Bank Plc confirmed its role in the filing, identifying itself as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the offer.
The bank purchased and sold 50,274 ordinary shares in Advanced Medical Solutions Group Plc during the dealing date of September 8, 2026.
Both the purchase and sale transactions were conducted at prices ranging from a low of 281 pence per unit to a high of 281.25 pence per unit.
The total number of shares purchased matched the total number sold, both coming in at exactly 50,274 ordinary shares, reflecting typical market-making activity by an exempt principal trader.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of the disclosure filing.
Investec confirmed there are no indemnity or option arrangements, nor any agreements or understandings relating to the relevant securities that could constitute an inducement to deal or refrain from dealing.
The bank also stated that no agreements or understandings exist relating to voting rights under any option or future acquisition and disposal of relevant securities linked to any derivative.
The disclosure was formally filed on September 9, 2026, with contact details listed under the name Abhishek Gawde, who can be reached via the telephone number provided in the regulatory submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure market transparency during offer periods.
The Panel’s Market Surveillance Unit remains available for consultation on dealing disclosure requirements under the Code for any parties with related enquiries.
